David J. Warren
- Researcher
- +47 22 93 46 87
Publications 2024
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials
Lancet Rheumatol, 6 (4), e226-e236
DOI 10.1016/S2665-9913(23)00341-7, PubMed 38402891
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16
J Immunother Cancer, 12 (4)
DOI 10.1136/jitc-2023-008179, PubMed 38604812
Editorial: Biocompatibility of implanted devices, modulation, and repair in the nervous system
Front Neurosci, 18, 1505912
DOI 10.3389/fnins.2024.1505912, PubMed 39529699
Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial
RMD Open, 10 (4)
DOI 10.1136/rmdopen-2024-004888, PubMed 39537558
A Multimodal Assistive-Robotic-Arm Control System to Increase Independence After Tetraplegia
IEEE Trans Neural Syst Rehabil Eng, 32, 2124-2133
DOI 10.1109/TNSRE.2024.3408833, PubMed 38829756
Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases
Rheumatology (Oxford), 63 (6), 1746-1755
DOI 10.1093/rheumatology/kead525, PubMed 37773994
Coeliac disease in the Trøndelag Health Study (HUNT), Norway, a population-based cohort of coeliac disease patients
BMJ Open, 14 (1), e077131
DOI 10.1136/bmjopen-2023-077131, PubMed 38195172
The Prevalence and Rate of Undiagnosed Celiac Disease in an Adult General Population, the Trøndelag Health Study, Norway
Clin Gastroenterol Hepatol (in press)
DOI 10.1016/j.cgh.2024.06.027, PubMed 38987013
Machine learning enables non-Gaussian investigation of changes to peripheral nerves related to electrical stimulation
Sci Rep, 14 (1), 2795
DOI 10.1038/s41598-024-53284-w, PubMed 38307915
Effects of prednisolone tapering on effectiveness of infliximab in patients with ulcerative colitis: data from a retrospective cohort
BMJ Open Gastroenterol, 11 (1)
DOI 10.1136/bmjgast-2024-001343, PubMed 38719549
Development of a feline model for preclinical research of a new translabyrinthine auditory nerve implant
Front Neurosci, 18, 1308663
DOI 10.3389/fnins.2024.1308663, PubMed 38379760
Subcutaneous Vedolizumab Treatment in a Real-World Inflammatory Bowel Disease Cohort Switched From Intravenous Vedolizumab: Eighteen-Month Prospective Follow-up Study
Crohns Colitis 360, 6 (1), otae013
DOI 10.1093/crocol/otae013, PubMed 38544907
Publications 2023
Transplacental passage of belimumab during pregnancy and follow-up of a child exposed in utero
Ann Rheum Dis, 82 (4), 577-579
DOI 10.1136/ard-2022-223684, PubMed 36604152
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases
J Intern Med, 293 (5), 648-655
DOI 10.1111/joim.13616, PubMed 36843323
Electrical Stimulation Induced Current Distribution in Peripheral Nerves Varies Significantly with the Extent of Nerve Damage: A Computational Study Utilizing Convolutional Neural Network and Realistic Nerve Models
Int J Neural Syst, 33 (4), 2350022
DOI 10.1142/S0129065723500223, PubMed 36916993
Humoral immune response to SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive medication: association to serum drug levels and disease type
Scand J Gastroenterol, 58 (8), 874-882
DOI 10.1080/00365521.2023.2177884, PubMed 36788656
Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring
Scand J Gastroenterol, 58 (8), 863-873
DOI 10.1080/00365521.2023.2176252, PubMed 36799155
Publications 2022
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study
Lancet Rheumatol, 5 (1), e36-e46
DOI 10.1016/S2665-9913(22)00330-7, PubMed 36415604
Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial
J Intern Med, 292 (3), 477-491
DOI 10.1111/joim.13495, PubMed 35411981
The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study
BMC Med, 20 (1), 378
DOI 10.1186/s12916-022-02587-8, PubMed 36199139
Drug Levels Associated With Optimal Discrimination Between Remission and Nonremission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease
Ther Drug Monit, 44 (2), 290-300
DOI 10.1097/FTD.0000000000000913, PubMed 34387220
The development and validation of a high-capacity serological assay for celiac disease
Clin Biochem, 107, 13-18
DOI 10.1016/j.clinbiochem.2022.05.010, PubMed 35660483
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy
RMD Open, 8 (2)
DOI 10.1136/rmdopen-2022-002417, PubMed 36328399
Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy
Arthritis Rheumatol, 74 (8), 1321-1332
DOI 10.1002/art.42153, PubMed 35507355
Publications 2021
Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort
Rheumatol Int, 41 (9), 1657-1665
DOI 10.1007/s00296-021-04865-9, PubMed 33944985
Serum etanercept concentrations in relation to disease activity and treatment response assessed by ultrasound, biomarkers and clinical disease activity scores: results from a prospective observational study of patients with rheumatoid arthritis
RMD Open, 7 (3)
DOI 10.1136/rmdopen-2021-001985, PubMed 34911811
Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study
Scand J Rheumatol, 50 (6), 445-454
DOI 10.1080/03009742.2021.1875040, PubMed 33650469
Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease
United European Gastroenterol J, 9 (1), 91-101
DOI 10.1177/2050640620964619, PubMed 33079627
BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors
Sci Rep, 11 (1), 11632
DOI 10.1038/s41598-021-91177-4, PubMed 34079038
Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study
Lancet Rheumatol, 4 (3), e177-e187
DOI 10.1016/S2665-9913(21)00394-5, PubMed 34977602
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial
JAMA, 325 (17), 1744-1754
DOI 10.1001/jama.2021.4172, PubMed 33944876
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial
JAMA, 326 (23), 2375-2384
DOI 10.1001/jama.2021.21316, PubMed 34932077
Publications 2020
Therapeutic thresholds and mechanisms for primary non-response to infliximab in inflammatory bowel disease
Scand J Gastroenterol, 55 (8), 884-890
DOI 10.1080/00365521.2020.1786852, PubMed 32631131
Falsely markedly elevated 25-hydroxyvitamin D in patients with monoclonal gammopathies
Clin Chem Lab Med, 59 (4), 663-669
DOI 10.1515/cclm-2020-1411, PubMed 33119540
Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials
BioDrugs, 34 (5), 681-694
DOI 10.1007/s40259-020-00438-7, PubMed 32965617
Simulation-Based Optimization of Figure-of-Eight Coil Designs and Orientations for Magnetic Stimulation of Peripheral Nerve
IEEE Trans Neural Syst Rehabil Eng, 28 (12), 2901-2913
DOI 10.1109/TNSRE.2020.3038406, PubMed 33201821
A Nonlinear Latching Filter to Remove Jitter From Movement Estimates for Prostheses
IEEE Trans Neural Syst Rehabil Eng, 28 (12), 2849-2858
DOI 10.1109/TNSRE.2020.3038706, PubMed 33201823
Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study)
Trials, 21 (1), 13
DOI 10.1186/s13063-019-3734-4, PubMed 31907007
Publications 2019
Real world data on effectiveness, safety and therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel disease. A single center cohort
Scand J Gastroenterol, 54 (1), 41-48
DOI 10.1080/00365521.2018.1548646, PubMed 30650312
Deep Learning Movement Intent Decoders Trained With Dataset Aggregation for Prosthetic Limb Control
IEEE Trans Biomed Eng, 66 (11), 3192-3203
DOI 10.1109/TBME.2019.2901882, PubMed 30835207
Associations between certolizumab pegol serum levels, anti-drug antibodies and treatment response in patients with inflammatory joint diseases: data from the NOR-DMARD study
Arthritis Res Ther, 21 (1), 256
DOI 10.1186/s13075-019-2009-5, PubMed 31783773
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial
J Intern Med, 285 (6), 653-669
DOI 10.1111/joim.12880, PubMed 30762274
Reduced Heat Generation During Magnetic Stimulation of Rat Sciatic Nerve Using Current Waveform Truncation
IEEE Trans Neural Syst Rehabil Eng, 27 (5), 937-946
DOI 10.1109/TNSRE.2019.2911054, PubMed 30990431
A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients
Ther Drug Monit, 41 (1), 11-18
DOI 10.1097/FTD.0000000000000580, PubMed 30633722
Selective stimulation of rat sciatic nerve using an array of mm-size magnetic coils: a simulation study
Healthc Technol Lett, 6 (3), 70-75
DOI 10.1049/htl.2018.5020, PubMed 31341631
Chimeric antigen receptor preparation from hybridoma to T-cell expression
Antib Ther, 2 (2), 56-63
DOI 10.1093/abt/tbz007, PubMed 33928223
Integrin α11β1 is expressed in breast cancer stroma and associates with aggressive tumor phenotypes
J Pathol Clin Res, 6 (1), 69-82
DOI 10.1002/cjp2.148, PubMed 31605508
Publications 2018
Combining Anti-TNF-α and Vedolizumab in the Treatment of Inflammatory Bowel Disease: A Case Series
Inflamm Bowel Dis, 24 (5), 997-1004
DOI 10.1093/ibd/izx110, PubMed 29668901
Selective Decrease in Allodynia With High-Frequency Neuromodulation via High-Electrode-Count Intrafascicular Peripheral Nerve Interface After Brachial Plexus Injury
Neuromodulation, 22 (5), 597-606
DOI 10.1111/ner.12802, PubMed 30117624
Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care
Scand J Rheumatol, 47 (5), 418-421
DOI 10.1080/03009742.2017.1376110, PubMed 29310493
Switching from originator to biosimilar infliximab - real world data of a prospective 18 months follow-up of a single-centre IBD population
Scand J Gastroenterol, 53 (6), 692-699
DOI 10.1080/00365521.2018.1463391, PubMed 29852793
Acquisition of Neural Action Potentials Using Rapid Multiplexing Directly at the Electrodes
Micromachines (Basel), 9 (10)
DOI 10.3390/mi9100477, PubMed 30424410
Pro-gastrin-releasing peptide and outcome in patients with heart failure and anaemia: results from the RED-HF study
ESC Heart Fail, 5 (6), 1052-1059
DOI 10.1002/ehf2.12312, PubMed 30145817
Publications 2017
Assays for Infliximab Drug Levels and Antibodies: A Matter of Scales and Categories
Scand J Immunol, 86 (3), 165-170
DOI 10.1111/sji.12572, PubMed 28561325
Switching from Remicade® to Remsima® is well Tolerated and Feasible: A Prospective, Open-label Study
J Crohns Colitis, 11 (3), 297-304
DOI 10.1093/ecco-jcc/jjw166, PubMed 27660339
Reusable High Aspect Ratio 3-D Nickel Shadow Mask
J Microelectromech Syst, 26 (2), 376-384
DOI 10.1109/JMEMS.2017.2654126, PubMed 29056835
Restoration of motor control and proprioceptive and cutaneous sensation in humans with prior upper-limb amputation via multiple Utah Slanted Electrode Arrays (USEAs) implanted in residual peripheral arm nerves
J Neuroeng Rehabil, 14 (1), 121
DOI 10.1186/s12984-017-0320-4, PubMed 29178940
Publications 2014
New General Medical Council language checks to be introduced in the summer. How will radiology reports fare?
Clin Radiol, 69 (9), 989-90
DOI 10.1016/j.crad.2014.04.017, PubMed 24924103
Publications 2013
Heterophilic antibody interference in immunometric assays
Best Pract Res Clin Endocrinol Metab, 27 (5), 647-61
DOI 10.1016/j.beem.2013.05.011, PubMed 24094636
Reply to 'The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors'
Mod Pathol, 26 (4), 613-5
DOI 10.1038/modpathol.2013.39, PubMed 23542526
Publications 2012
A man with abdominal pain: enough evidence for surgery?
Clin Chem, 58 (8), 1187-90
DOI 10.1373/clinchem.2011.167015, PubMed 22843812
Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera (vol 49, pg 2001, 2011)
Clin. Chem. Lab. Med., 50 (2), 409
DOI 10.1515/cclm-2012-0038
Separation principles of cycling temperature capillary electrophoresis
Electrophoresis, 33 (7), 1162-8
DOI 10.1002/elps.201100550, PubMed 22539319
Characteristics and clinical validity of two immunoassays for ProGRP
Tumour Biol, 33 (4), 1105-13
DOI 10.1007/s13277-012-0351-1, PubMed 22399443
Publications 2011
Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera
Clin Chem Lab Med, 49 (12), 2001-6
DOI 10.1515/CCLM.2011.702, PubMed 21899496
TD-12 workshop report: characterization of monoclonal antibodies to neuron-specific enolase
Tumour Biol, 32 (4), 819-29
DOI 10.1007/s13277-011-0184-3, PubMed 21573737
The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors
Mod Pathol, 25 (4), 537-47
DOI 10.1038/modpathol.2011.188, PubMed 22157935
Preparation of highly efficient electrocompetent Escherichia coli using glycerol/mannitol density step centrifugation
Anal Biochem, 413 (2), 206-7
DOI 10.1016/j.ab.2011.02.036, PubMed 21362398
Publications 2009
Studies on multiple forms of proGRP in serum from small cell lung cancer patients
Tumour Biol, 30 (5-6), 265-75
DOI 10.1159/000258135, PubMed 19907206
Characterization of monoclonal antibodies directed against squamous cell carcinoma antigens: report of the second TD-10 workshop
Tumour Biol, 30 (1), 26-36
DOI 10.1159/000199448, PubMed 19194112
Formulation of immunoassay calibrators in pasteurized albumin can significantly enhance their durability
J Immunol Methods, 353 (1-2), 145-7
DOI 10.1016/j.jim.2009.12.001, PubMed 20006616
Expression and epitope characterization of a recombinant CA 125 repeat: fourth report from the ISOBM TD-1 workshop
Tumour Biol, 30 (2), 51-60
DOI 10.1159/000209988, PubMed 19321947
Publications 2008
Progastrin-releasing peptide: stability in plasma/serum and upper reference limit
Tumour Biol, 29 (3), 204-10
DOI 10.1159/000148188, PubMed 18667845
Automated time-resolved immunofluorometric assay for progastrin-releasing peptide
Clin Chem, 54 (5), 919-22
DOI 10.1373/clinchem.2007.101436, PubMed 18443179
Publications 2007
Production and Characterization of Monoclonal Antibodies for Immunoassay of the Lung Cancer Marker proGRP
Tumour Biol, 28 (2), 100-10
DOI 10.1159/000099335, PubMed 17287611
Publications 2006
High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection
BMC Clin Pharmacol, 6, 2
DOI 10.1186/1472-6904-6-2, PubMed 16412237
Publications 2005
High-throughput gender determination using automated denaturant gel capillary electrophoresis
Electrophoresis, 26 (13), 2562-6
DOI 10.1002/elps.200410392, PubMed 15934052
Use of an in vivo biotinylated single-chain antibody as capture reagent in an immunometric assay to decrease the incidence of interference from heterophilic antibodies
Clin Chem, 51 (5), 830-8
DOI 10.1373/clinchem.2004.046979, PubMed 15718486
Publications 2004
The detection of hamster connexins: a comparison of expression profiles with wild-type mouse and the cancer-prone Min mouse
Cell Commun Adhes, 11 (5-6), 155-71
DOI 10.1080/15419060500242877, PubMed 16194882
Determination of hereditary mutations in the BRCA1 gene using archived serum samples and capillary electrophoresis
Anal Chem, 76 (15), 4406-9
DOI 10.1021/ac049788k, PubMed 15283579
Publications 2003
A single-chain-Fv-based immunofluorometric assay specific for the CEA variant NCA-2
J Immunol Methods, 283 (1-2), 125-39
DOI 10.1016/j.jim.2003.08.018, PubMed 14659905
Publications 2001
Development of a rapid and sensitive immunofluorometric assay for glutathione S-transferase A
Clin Chem, 47 (5), 867-73
PubMed 11325890
CA 125: the end of the beginning
Tumour Biol, 22 (6), 345-7
DOI 10.1159/000050637, PubMed 11786728
Effect of the glutathione/glutathione disulfide redox couple on thiopurine methyltransferase
Biochem Pharmacol, 61 (6), 707-14
DOI 10.1016/s0006-2952(01)00528-7, PubMed 11266655
Publications 2000
A comparison of the effects of nine folate analogs on early and late murine hematopoietic progenitor cells in vitro
Cancer Chemother Pharmacol, 45 (6), 450-6
DOI 10.1007/s002800051018, PubMed 10854131
Publications 1999
Determination of mitotane (o,p-DDD) and its metabolites o,p-DDA and o,p-DDE in plasma by high-performance liquid chromatography
Ther Drug Monit, 21 (3), 355-9
DOI 10.1097/00007691-199906000-00020, PubMed 10365653
Publications 1996
Determination of extracellular methotrexate tissue levels by microdialysis in a rat model
Cancer Chemother Pharmacol, 37 (5), 394-400
DOI 10.1007/s002800050403, PubMed 8599860
Differential effects of the antifolates methotrexate, aminopterin and trimetrexate on murine haemopoietic progenitor cells
Br J Haematol, 92 (3), 514-20
DOI 10.1046/j.1365-2141.1996.d01-50.x, PubMed 8616011
Publications 1995
A high-pressure liquid chromatographic method for measuring mitotane [1,1-(o,p'-Dichlorodiphenyl)-2,2-dichloroethane] and its metabolite 1,1-(o,p'-Dichlorodiphenyl)-2,2-dichloroethene in plasma
Ther Drug Monit, 17 (5), 526-31
DOI 10.1097/00007691-199510000-00015, PubMed 8585118
Qualitatively different mechanisms of resistance to doxorubicin, both involving altered glutathione pools, in two myeloid cell lines in vitro
Pediatr Hematol Oncol, 12 (6), 531-44
DOI 10.3109/08880019509030767, PubMed 8588998
Pharmacokinetics of different doses of methotrexate at steady state by in situ microdialysis in a rat model
Cancer Chemother Pharmacol, 36 (4), 283-9
DOI 10.1007/BF00689044, PubMed 7628046
Establishment and characterization of a novel hepatoblastoma-derived cell line
J Pediatr Surg, 30 (4), 553-8
DOI 10.1016/0022-3468(95)90129-9, PubMed 7595832
Effect of methotrexate on murine bone marrow cells in vitro: evidence of a reversible antiproliferative action
Exp Hematol, 23 (5), 439-43
PubMed 7720815
Quantitation of 6-thioguanine residues in peripheral blood leukocyte DNA obtained from patients receiving 6-mercaptopurine-based maintenance therapy
Cancer Res, 55 (8), 1670-4
PubMed 7712473
Publications 1994
Quantitation of cell-associated doxorubicin by high-performance liquid chromatography after enzymatic desequestration
Cancer Chemother Pharmacol, 34 (3), 197-202
DOI 10.1007/BF00685077, PubMed 8004751
Evaluation of methotrexate tissue exposure by in situ microdialysis in a rat model
Cancer Chemother Pharmacol, 34 (4), 297-301
DOI 10.1007/BF00686036, PubMed 8033296
Publications 1993
A sensitive and simple high-performance liquid chromatographic method for the determination of doxorubicin and its metabolites in plasma
Ther Drug Monit, 15 (5), 455-61
DOI 10.1097/00007691-199310000-00016, PubMed 8249054
A simple HPLC method for the determination of cellular glutathione
Pharmacol Toxicol, 73 (2), 124-6
DOI 10.1111/j.1600-0773.1993.tb01548.x, PubMed 8248008
A sensitive and simple high-performance liquid chromatographic method for the determination of mitoxantrone in plasma
Ther Drug Monit, 15 (4), 328-33
DOI 10.1097/00007691-199308000-00011, PubMed 8236369
Effect of nitrous oxide on haematopoiesis in vitro: biochemical and functional features
Pharmacol Toxicol, 72 (1), 69-72
DOI 10.1111/j.1600-0773.1993.tb01342.x, PubMed 8441744
A high-performance liquid chromatographic method for the determination of 6-thioguanine residues in DNA using precolumn derivatization and fluorescence detection
Anal Biochem, 215 (2), 278-83
DOI 10.1006/abio.1993.1587, PubMed 8122790
Induction of a reversible block in murine CFU-C differentiation by exposure to nitrous oxide
Exp Hematol, 21 (2), 345-9
PubMed 8425570
A sensitive high-performance liquid chromatographic method for the determination of 6-mercaptopurine in plasma using precolumn derivatization and fluorescence detection
Ther Drug Monit, 15 (1), 25-30
DOI 10.1097/00007691-199302000-00004, PubMed 8451776
Publications 1990
Influence of interleukins 3,5, and 6 on the growth of eosinophil progenitors in highly enriched human bone marrow in the absence of serum
Exp Hematol, 18 (11), 1180-6
PubMed 1699774
Cytokine networks involved in the regulation of haemopoietic stem cell proliferation and differentiation
Ciba Found Symp, 148, 43-58; discussion 58-61
DOI 10.1002/9780470513880.ch4, PubMed 2180648
Protective effects of tumor necrosis factor on murine hematopoiesis during cycle-specific cytotoxic chemotherapy
Cancer Res, 50 (14), 4216-20
PubMed 2364379
Tumor-necrosis factor induces cell cycle arrest in multipotential hematopoietic stem cells: a possible radioprotective mechanism
Eur J Haematol, 45 (3), 158-63
DOI 10.1111/j.1600-0609.1990.tb00444.x, PubMed 2226728
Publications 1989
Modulation of colony-stimulating factor-1 receptors on macrophages by tumor necrosis factor
J Immunol, 143 (8), 2534-9
PubMed 2551961
Radioprotection by murine and human tumor-necrosis factor: dose-dependent effects on hematopoiesis in the mouse
Eur J Haematol, 43 (5), 428-34
DOI 10.1111/j.1600-0609.1989.tb00331.x, PubMed 2612616
Effect of recombinant murine tumor necrosis factor on hemopoietic reconstitution in sublethally irradiated mice
J Immunol, 142 (3), 833-5
PubMed 2913152
Publications 1988
Correction of canine cyclic hematopoiesis with recombinant human granulocyte colony-stimulating factor
Blood, 72 (4), 1324-8
PubMed 2458781
Enhancement of release of granulocyte- and granulocyte-macrophage colony-stimulating factors from phytohemagglutinin-stimulated sorted subsets of human T lymphocytes by recombinant human tumor necrosis factor-alpha. Synergism with recombinant human IFN-gamma
J Immunol, 141 (1), 201-7
PubMed 2454257
The biology of murine eosinophil differentiation factor (an overview)
Behring Inst Mitt (83), 98-101
PubMed 3071351
Synergism among interleukin 1, interleukin 3, and interleukin 5 in the production of eosinophils from primitive hemopoietic stem cells
J Immunol, 140 (1), 94-9
PubMed 3257232
Publications 1987
Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice
Proc Natl Acad Sci U S A, 84 (20), 7134-8
DOI 10.1073/pnas.84.20.7134, PubMed 3499607
Acute renal failure: diagnosis of cause needed within hours
Br Med J (Clin Res Ed), 294 (6587), 1569
DOI 10.1136/bmj.294.6587.1569, PubMed 3113534
Publications 1986
Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors
Blood, 68 (1), 162-6
PubMed 3487354
Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells
J Exp Med, 163 (5), 1085-99
DOI 10.1084/jem.163.5.1085, PubMed 3486243
Interleukin 4 (B-cell growth factor II/eosinophil differentiation factor) is a mitogen and differentiation factor for preactivated murine B lymphocytes
Proc Natl Acad Sci U S A, 83 (14), 5228-32
DOI 10.1073/pnas.83.14.5228, PubMed 3487787
Effects of cyclosporine on responses of murine B cells to T cell-derived lymphokines
J Immunol, 137 (7), 2220-4
PubMed 3489759
Interleukin-4 (B cell growth factor-II/eosinophil differentiation factor) is a mitogen and differentiation factor for preactivated murine B lymphocytes
Curr Top Microbiol Immunol, 132, 133-41
DOI 10.1007/978-3-642-71562-4_18, PubMed 3491734
Comparison of the effects of atenolol, sotalol and labetalol on muscle blood flow in man
Postgrad Med J, 62 (731), 841-4
DOI 10.1136/pgmj.62.731.841, PubMed 2880341
Eosinophil differentiation factor also has B-cell growth factor activity: proposed name interleukin 4
Proc Natl Acad Sci U S A, 83 (2), 437-40
DOI 10.1073/pnas.83.2.437, PubMed 3484551
Publications 1985
The effect of age on the cardiovascular responses to isometric exercise: a test of autonomic function
Gerontology, 31 (1), 54-8
DOI 10.1159/000212681, PubMed 3972256
Effect of haemodialysis on the control of the circulation in patients with chronic renal failure
Am J Nephrol, 5 (2), 96-102
DOI 10.1159/000166913, PubMed 3887923
The production of lymphokines by primary alloreactive T-cell clones: a co-ordinate analysis of 233 clones in seven lymphokine assays
Immunology, 56 (4), 575-84
PubMed 3935571
Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures
J Exp Med, 162 (1), 60-74
DOI 10.1084/jem.162.1.60, PubMed 3925072
Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors
J Immunol Methods, 83 (2), 209-15
DOI 10.1016/0022-1759(85)90242-x, PubMed 3840509
The effect of captopril on autonomic reflexes in human hypertension
J Hypertens Suppl, 3 (2), S111-5
PubMed 3910766
A comparison of the effects of intravenous propranolol and nadolol on the renal response to hypertonic saline infusion
Br J Clin Pharmacol, 19 (1), 37-43
DOI 10.1111/j.1365-2125.1985.tb02610.x, PubMed 2858216
Production of a T-cell hybrid producing a lymphokine stimulating eosinophil differentiation
Immunology, 54 (4), 615-23
PubMed 2579895